ChartRow logo
Share this page
MEDP
$599.47+0.23%
as of close, Oct 2, 2026
☾ AH $599.47 +0.23%
Medpace Holdings Inc.Stock · Health CareRussell 1000 0.02%US Stock Market 0.02%Russell 3000 0.02%
PeersMRNALLYUNHJNJMRKTMO

MEDP SEC filings (2026)

CIK 1668397 · Services-Commercial Physical & Biological Research (SIC 8731) · incorporated in DE · fiscal year ends in December

920 filings on EDGAR since 2016 · 10 annual, 30 quarterly, 89 current · financial statements · earnings

Latest 10-K
Feb 10, 2026
fiscal year to Dec 31, 2025
Latest 10-Q
Jul 23, 2026
quarter to Jun 30, 2026
Latest 8-K
Jul 22, 2026
Results of operations
Last earnings release
Jul 22, 2026
$4.25 vs $4.08 · ▲ 14.7%
Filings on file
920
since 2016, 651 insider forms

What happened, last 12 months#

Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.

September 2026

August 2026

July 2026

June 2026

May 2026

April 2026

March 2026

February 2026

October 2025

Insider transactions#

What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.

Over the last 13 months insiders sold $230.3M in 33 sales and bought nothing on the open market; 64 other transactions (awards, exercises, tax withholding, gifts and plan purchases).

DateInsider
Sep 30, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $13.7M · 21,966 sh
Sep 29, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $16.6M · 26,701 sh
Sep 28, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $1.5M · 2,410 sh
Sep 25, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $96K · 154 sh
Sep 24, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $17.3M · 27,833 sh
Sep 23, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $10.1M · 16,083 sh
Sep 22, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $30.8M · 49,018 sh
Sep 21, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $13.6M · 21,883 sh
Sep 17, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $6.7M · 10,880 sh
Sep 16, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $5.4M · 8,770 sh
Sep 15, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $9.9M · 15,971 sh
Aug 27, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $403K · 650 sh
Aug 26, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $2.5M · 4,000 sh
Aug 26, 2026Form 4Kraft Robert O.DirectorSold · $2.4M · 3,858 sh
Aug 25, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $418K · 673 sh
Aug 24, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $1.2M · 1,983 sh
Aug 21, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $8.7M · 13,995 sh
Aug 20, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $16.8M · 27,174 sh
Aug 20, 2026Form 4Brady Kevin M.CFO & TreasurerSold · $2.1M · 3,400 sh
Aug 19, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $9.5M · 15,609 sh
Aug 19, 2026Form 4DAVENPORT FRED B JRDirectorSold · $4.4M · 7,283 sh
Aug 19, 2026Form 4Carley Brian TDirectorSold · $3.0M · 5,000 sh
Aug 13, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $275K · 458 sh
Aug 12, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $6.8M · 11,366 sh
Aug 11, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $10.7M · 17,610 sh
Aug 11, 2026Form 4McCarthy Cornelius P. IIIDirectorSold · $690K · 1,140 sh
Aug 10, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $3.3M · 5,534 sh
Aug 7, 2026Form 4McCarthy Cornelius P. IIIDirectorSold · $465K · 795 sh
Jul 28, 2026Form 4BURWIG SUSAN EExec. VP, OperationsSold · $4.5M · 7,500 sh
Jul 28, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $2.1M · 3,510 sh
Jul 27, 2026Form 4Troendle August J.President & CEO · Director · 10% ownerSold · $2.2M · 3,728 sh
May 28, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Sold · $7.4M · 16,349 sh
Mar 17, 2026Form 4GEIGER JESSE JPresidentSold · $14.4M · 31,707 sh
Awards, exercises, withholding and plan purchases · 64 transactions
DateInsider
Sep 30, 2026Form 4Carley Brian TDirectorExercise or conversion · — · 36 sh
Sep 30, 2026Form 4Carley Brian TDirectorExercise or conversion · Restricted Stock Unit · $0 · 36 sh
Sep 30, 2026Form 4Kraft Robert O.DirectorExercise or conversion · — · 32 sh
Sep 30, 2026Form 4Kraft Robert O.DirectorExercise or conversion · Restricted Stock Unit · $0 · 32 sh
Sep 30, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · — · 28 sh
Sep 30, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · Restricted Stock Unit · $0 · 28 sh
Sep 15, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · $500K · 3,000 sh
Sep 15, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · Employee Stock Option (Rig… · $0 · 3,000 sh
Aug 26, 2026Form 4Kraft Robert O.DirectorExercise or conversion · $325K · 3,858 sh
Aug 26, 2026Form 4Kraft Robert O.DirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 3,858 sh
Aug 20, 2026Form 4Brady Kevin M.CFO & TreasurerExercise or conversion · $472K · 3,400 sh
Aug 20, 2026Form 4Brady Kevin M.CFO & TreasurerExercise or conversion · Employee Stock Option (Rig… · $0 · 3,400 sh
Aug 19, 2026Form 4DAVENPORT FRED B JRDirectorExercise or conversion · $880K · 7,583 sh
Aug 19, 2026Form 4DAVENPORT FRED B JRDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 7,583 sh
Aug 7, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · $325K · 3,858 sh
Aug 7, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 3,858 sh
Jun 30, 2026Form 4Carley Brian TDirectorExercise or conversion · — · 36 sh
Jun 30, 2026Form 4Carley Brian TDirectorExercise or conversion · Restricted Stock Unit · $0 · 36 sh
Jun 30, 2026Form 4Kraft Robert O.DirectorExercise or conversion · — · 33 sh
Jun 30, 2026Form 4Kraft Robert O.DirectorExercise or conversion · Restricted Stock Unit · $0 · 33 sh
Jun 30, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · — · 28 sh
Jun 30, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · Restricted Stock Unit · $0 · 28 sh
May 28, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · $2.3M · 16,349 sh
May 28, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · Employee Stock Option (Rig… · $0 · 16,349 sh
May 15, 2026Form 4DAVENPORT FRED B JRDirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
May 15, 2026Form 4Kraft Robert O.DirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
May 15, 2026Form 4Carley Brian TDirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
May 15, 2026Form 4McCarthy Cornelius P. IIIDirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
May 15, 2026Form 4Gwadry-Sridhar Femida H.DirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
May 15, 2026Form 4Zander Dani S.DirectorAward · Stock Option (Right to Buy) · $0 · 1,110 sh
Apr 24, 2026Form 4Brady Kevin M.CFO & TreasurerExercise or conversion · $972K · 7,000 sh
Apr 24, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · $486K · 3,500 sh
Apr 24, 2026Form 4Troendle August J.CEO · Director · 10% ownerAward · Employee Stock Option (Rig… · $0 · 20,000 sh
Apr 24, 2026Form 4Troendle August J.CEO · Director · 10% ownerAward · Restricted Stock Unit · $0 · 10,000 sh
Apr 24, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Award · Employee Stock Option (Rig… · $0 · 10,000 sh
Apr 24, 2026Form 4BURWIG SUSAN EExec. VP, OperationsAward · Employee Stock Option (Rig… · $0 · 10,000 sh
Apr 24, 2026Form 4Brady Kevin M.CFO & TreasurerAward · Employee Stock Option (Rig… · $0 · 10,000 sh
Apr 24, 2026Form 4Brady Kevin M.CFO & TreasurerExercise or conversion · Employee Stock Option (Rig… · $0 · 7,000 sh
Apr 24, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Award · Restricted Stock Unit · $0 · 5,000 sh
Apr 24, 2026Form 4BURWIG SUSAN EExec. VP, OperationsAward · Restricted Stock Unit · $0 · 5,000 sh
Apr 24, 2026Form 4Brady Kevin M.CFO & TreasurerAward · Restricted Stock Unit · $0 · 5,000 sh
Apr 24, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · Employee Stock Option (Rig… · $0 · 3,500 sh
Mar 31, 2026Form 4Carley Brian TDirectorExercise or conversion · — · 36 sh
Mar 31, 2026Form 4Carley Brian TDirectorExercise or conversion · Restricted Stock Unit · $0 · 36 sh
Mar 31, 2026Form 4Kraft Robert O.DirectorExercise or conversion · — · 33 sh
Mar 31, 2026Form 4Kraft Robert O.DirectorExercise or conversion · Restricted Stock Unit · $0 · 33 sh
Mar 31, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · — · 29 sh
Mar 31, 2026Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · Restricted Stock Unit · $0 · 29 sh
Mar 18, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · $2.0M · 12,000 sh
Mar 18, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · Employee Stock Option (Rig… · $0 · 12,000 sh
Mar 17, 2026Form 4GEIGER JESSE JPresidentExercise or conversion · $4.4M · 31,707 sh
Mar 17, 2026Form 4GEIGER JESSE JPresidentExercise or conversion · Employee Stock Option (Rig… · $0 · 31,707 sh
Feb 17, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · $486K · 3,500 sh
Feb 17, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.Exercise or conversion · Employee Stock Option (Rig… · $0 · 3,500 sh
Feb 13, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · $1.2M · 10,984 sh
Feb 13, 2026Form 4Carley Brian TDirectorExercise or conversion · $356K · 6,472 sh
Feb 13, 2026Form 4BURWIG SUSAN EExec. VP, OperationsExercise or conversion · Employee Stock Option (Rig… · $0 · 10,984 sh
Feb 13, 2026Form 4Carley Brian TDirectorExercise or conversion · Stock Option (Right to Buy) · $0 · 6,472 sh
Dec 31, 2025Form 4Carley Brian TDirectorExercise or conversion · — · 62 sh
Dec 31, 2025Form 4Carley Brian TDirectorExercise or conversion · Restricted Stock Unit · $0 · 62 sh
Dec 31, 2025Form 4Kraft Robert O.DirectorExercise or conversion · — · 56 sh
Dec 31, 2025Form 4Kraft Robert O.DirectorExercise or conversion · Restricted Stock Unit · $0 · 56 sh
Dec 31, 2025Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · — · 49 sh
Dec 31, 2025Form 4McCarthy Cornelius P. IIIDirectorExercise or conversion · Restricted Stock Unit · $0 · 49 sh

Reports and proxy statements#

Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).

2026 · 12 filings
FiledWhat it is
Jul 23, 202610-QQuarterly report, Q2 2026 — revenue $707.3M (+17% y/y), net income $121.4M, EPS $4.25
Jul 22, 20268-KEarnings release — EPS $4.25 vs $4.08 est. (+4.2%); revenue $707.3M (+17% y/y) 14.7%
Jun 4, 20268-KDirectors or officers; compensation
May 19, 20268-KCharter, bylaws or fiscal-year change; Shareholder vote results
Apr 23, 202610-QQuarterly report, Q1 2026 — revenue $706.6M (+27% y/y), net income $123.9M, EPS $4.28
Apr 22, 20268-KEarnings release — EPS $4.28 vs $3.74 est. (+14.4%); revenue $706.6M (+27% y/y) 22.6%
Apr 1, 2026DEFA14AAdditional proxy materials
Apr 1, 2026DEF 14AProxy statement
Apr 1, 2026ARSAnnual report to shareholders
Mar 16, 2026PRE 14APreliminary proxy statement
Feb 10, 202610-KAnnual report, FY2025 — revenue $2.53B (+20% y/y), net income $451.1M, EPS $15.28
Feb 9, 20268-KEarnings release — EPS $4.67 vs $4.18 est. (+11.7%); revenue $708.5M (+32% y/y) 15.9%
2025 · 13 filings
FiledWhat it is
Oct 23, 202510-QQuarterly report, Q3 2025 — revenue $659.9M (+24% y/y), net income $111.1M, EPS $3.86
Oct 22, 20258-KEarnings release — EPS $3.86 vs $3.50 est. (+10.3%); revenue $659.9M (+24% y/y) 9.1%
Jul 22, 202510-QQuarterly report, Q2 2025 — revenue $603.3M (+14% y/y), net income $90.3M, EPS $3.10
Jul 21, 20258-KMaterial definitive agreement; Results of operations
May 16, 20258-KDirectors or officers; compensation; Shareholder vote results
Apr 22, 202510-QQuarterly report, Q1 2025 — revenue $558.6M (+9% y/y), net income $114.6M, EPS $3.67
Apr 21, 20258-KMaterial definitive agreement; Results of operations; Other events
Apr 2, 2025DEFA14AAdditional proxy materials
Apr 2, 2025DEF 14AProxy statement
Apr 2, 2025ARSAnnual report to shareholders
Mar 31, 20258-KMaterial definitive agreement
Feb 11, 202510-KAnnual report, FY2024 — revenue $2.11B (+12% y/y), net income $404.4M, EPS $12.63
Feb 10, 20258-KResults of operations; Other events
2024 · 15 filings
FiledWhat it is
Oct 22, 202410-QQuarterly report, Q3 2024 — revenue $533.3M (+8% y/y), net income $96.4M, EPS $3.01
Oct 21, 20248-KResults of operations
Jul 23, 202410-QQuarterly report, Q2 2024 — revenue $528.1M (+15% y/y), net income $88.4M, EPS $2.75
Jul 22, 20248-KResults of operations
Jul 3, 20248-KDirectors or officers; compensation
May 21, 20248-KCharter, bylaws or fiscal-year change; Shareholder vote results
Apr 23, 202410-QQuarterly report, Q1 2024 — revenue $511.0M (+18% y/y), net income $102.6M, EPS $3.20
Apr 22, 20248-KResults of operations
Apr 3, 2024DEFA14AAdditional proxy materials
Apr 3, 2024DEF 14AProxy statement
Apr 3, 2024ARSAnnual report to shareholders
Mar 29, 20248-KMaterial definitive agreement
Mar 20, 2024PRE 14APreliminary proxy statement
Feb 13, 202410-KAnnual report, FY2023 — revenue $1.89B (+29% y/y), net income $282.8M, EPS $8.88
Feb 12, 20248-KResults of operations
2023 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
FiledWhat it is
Oct 24, 202310-QQuarterly report, Q3 2023 — revenue $492.5M (+28% y/y), net income $70.5M, EPS $2.22
Jul 25, 202310-QQuarterly report, Q2 2023 — revenue $460.9M (+31% y/y), net income $61.1M, EPS $1.93
Apr 25, 202310-QQuarterly report, Q1 2023 — revenue $434.1M (+31% y/y), net income $72.9M, EPS $2.27
Apr 5, 2023DEFA14AAdditional proxy materials
Apr 5, 2023DEF 14AProxy statement
Apr 5, 2023ARSAnnual report to shareholders
Feb 14, 202310-KAnnual report, FY2022 — revenue $1.46B (+28% y/y), net income $245.4M, EPS $7.28

8 current reports (8-K) not listed; the year is on EDGAR.

2022 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 25, 202210-QQuarterly report, Q3 2022 — revenue $383.7M (+30% y/y), net income $66.0M, EPS $2.05
Jul 26, 202210-QQuarterly report, Q2 2022 — revenue $351.2M (+26% y/y), net income $49.4M, EPS $1.46
Apr 26, 202210-QQuarterly report, Q1 2022 — revenue $330.9M (+27% y/y), net income $61.3M, EPS $1.69
Apr 6, 2022DEFA14AAdditional proxy materials
Apr 6, 2022DEF 14AProxy statement
Feb 15, 202210-KAnnual report, FY2021 — revenue $1.14B (+23% y/y), net income $181.8M, EPS $4.81

8 current reports (8-K) not listed; the year is on EDGAR.

2021 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 26, 202110-QQuarterly report, Q3 2021 — revenue $295.6M (+28% y/y), net income $48.6M, EPS $1.29
Jul 27, 202110-QQuarterly report, Q2 2021 — revenue $278.3M (+36% y/y), net income $39.9M, EPS $1.06
Apr 27, 202110-QQuarterly report, Q1 2021 — revenue $260.0M (+13% y/y), net income $43.3M, EPS $1.14
Mar 30, 2021DEFA14AAdditional proxy materials
Mar 30, 2021DEF 14AProxy statement
Feb 16, 202110-KAnnual report, FY2020 — revenue $925.9M (+8% y/y), net income $145.4M, EPS $3.84

10 current reports (8-K) not listed; the year is on EDGAR.

2020 · 14 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 27, 202010-QQuarterly report, Q3 2020 — revenue $230.4M (+7% y/y), net income $41.5M, EPS $1.09
Jul 28, 202010-QQuarterly report, Q2 2020 — revenue $205.0M (−4% y/y), net income $24.1M, EPS $0.64
Apr 29, 202010-QQuarterly report, Q1 2020 — revenue $230.9M (+15% y/y), net income $29.0M, EPS $0.76
Apr 1, 2020DEFA14AAdditional proxy materials
Apr 1, 2020DEF 14AProxy statement
Feb 25, 202010-KAnnual report, FY2019 — revenue $861.0M (+22% y/y), net income $100.4M, EPS $2.67

8 current reports (8-K) not listed; the year is on EDGAR.

2019 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 29, 201910-QQuarterly report, Q3 2019 — revenue $216.2M (+21% y/y), net income $24.0M, EPS $0.63
Jul 30, 201910-QQuarterly report, Q2 2019 — revenue $214.1M (+26% y/y), net income $27.5M, EPS $0.73
Apr 30, 201910-QQuarterly report, Q1 2019 — revenue $200.7M (+23% y/y), net income $19.2M, EPS $0.51
Apr 3, 2019DEFA14AAdditional proxy materials
Apr 3, 2019DEF 14AProxy statement
Feb 26, 201910-KAnnual report, FY2018 — revenue $704.6M (+62% y/y), net income $73.2M, EPS $1.97

10 current reports (8-K) not listed; the year is on EDGAR.

2018 · 19 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 30, 201810-QQuarterly report, Q3 2018 — revenue $179.3M (+62% y/y), net income $19.3M, EPS $0.52
Jul 31, 201810-QQuarterly report, Q2 2018 — revenue $170.1M (+60% y/y), net income $16.6M, EPS $0.45
May 1, 201810-QQuarterly report, Q1 2018 — revenue $163.1M (+53% y/y), net income $14.6M, EPS $0.40
Apr 5, 2018DEFA14AAdditional proxy materials
Apr 5, 2018DEF 14AProxy statement
Feb 27, 201810-KAnnual report, FY2017 — revenue $436.2M (+3% y/y), net income $39.1M, EPS $0.98

13 current reports (8-K) not listed; the year is on EDGAR.

2017 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
FiledWhat it is
Oct 31, 201710-QQuarterly report, Q3 2017 — revenue $110.6M (+3% y/y), net income $9.8M, EPS $0.25
Aug 1, 201710-QQuarterly report, Q2 2017 — revenue $106.2M (+0% y/y), net income $9.6M, EPS $0.23
May 2, 201710-QQuarterly report, Q1 2017 — revenue $106.6M (+7% y/y), net income $8.4M, EPS $0.20
Apr 5, 2017DEFA14AAdditional proxy materials
Apr 5, 2017DEF 14AProxy statement
Feb 28, 201710-KAnnual report, FY2016 — revenue $421.6M (+17% y/y), net income $13.4M, EPS $0.37

10 current reports (8-K) not listed; the year is on EDGAR.

2016 · 5 filings — 4 × 8-K, 1 × 10-Q

Counted, not listed; the year is on EDGAR.

Insider, ownership and other filings#

Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.

2026 · 66 filings — 49 × 4, 12 × 144, 1 × 144/A and 4 other forms
FiledWhat it is
Oct 2, 20264Insider transaction (Form 4)
Oct 2, 20264Insider transaction (Form 4)
Oct 2, 20264Insider transaction (Form 4)
Oct 1, 20264Insider transaction (Form 4)
Sep 29, 20264Insider transaction (Form 4)
Sep 28, 2026SCHEDULE 13D/AOther filings
Sep 25, 20264Insider transaction (Form 4)
Sep 23, 20264Insider transaction (Form 4)
Sep 21, 20264Insider transaction (Form 4)
Sep 17, 20264Insider transaction (Form 4)
Sep 17, 20264Insider transaction (Form 4)
Aug 31, 20264Insider transaction (Form 4)
Aug 28, 20264Insider transaction (Form 4)
Aug 27, 20264Insider transaction (Form 4)
Aug 26, 2026144Notice of proposed sale (Form 144)
Aug 25, 20264Insider transaction (Form 4)
Aug 24, 20264Insider transaction (Form 4)
Aug 21, 20264Insider transaction (Form 4)
Aug 21, 20264Insider transaction (Form 4)
Aug 21, 20264Insider transaction (Form 4)
Aug 20, 2026144Notice of proposed sale (Form 144)
Aug 19, 2026144Notice of proposed sale (Form 144)
Aug 19, 2026144Notice of proposed sale (Form 144)
Aug 14, 20264Insider transaction (Form 4)
Aug 14, 2026SCHEDULE 13GOther filings

The newest 25 of 66 shown; the full year is on EDGAR.

2025 · 86 filings — 61 × 4, 22 × 144, 2 × SCHEDULE 13D/A and 1 other form
FiledWhat it is
Dec 9, 20254Insider transaction (Form 4)
Dec 4, 20254Insider transaction (Form 4)
Dec 4, 20254Insider transaction (Form 4)
Dec 3, 20254Insider transaction (Form 4)
Dec 2, 20254Insider transaction (Form 4)
Dec 2, 20254Insider transaction (Form 4)
Dec 2, 20254Insider transaction (Form 4)
Dec 1, 2025SCHEDULE 13D/AOther filings
Dec 1, 20254Insider transaction (Form 4)
Nov 26, 20254Insider transaction (Form 4)
Nov 26, 20254Insider transaction (Form 4)
Nov 25, 2025144Notice of proposed sale (Form 144)
Nov 25, 20254Insider transaction (Form 4)
Nov 24, 20254Insider transaction (Form 4)
Nov 24, 2025144Notice of proposed sale (Form 144)
Nov 21, 2025144Notice of proposed sale (Form 144)
Nov 20, 20254Insider transaction (Form 4)
Nov 18, 20254Insider transaction (Form 4)
Nov 18, 20254Insider transaction (Form 4)
Nov 14, 20254Insider transaction (Form 4)
Nov 14, 2025144Notice of proposed sale (Form 144)
Nov 12, 2025144Notice of proposed sale (Form 144)
Nov 12, 20254Insider transaction (Form 4)
Nov 12, 2025144Notice of proposed sale (Form 144)
Nov 7, 20254Insider transaction (Form 4)

The newest 25 of 86 shown; the full year is on EDGAR.

2024 · 98 filings — 64 × 4, 27 × 144, 3 × SC 13G/A and 3 other forms
FiledWhat it is
Dec 10, 20244Insider transaction (Form 4)
Dec 3, 20244Insider transaction (Form 4)
Dec 3, 20244Insider transaction (Form 4)
Dec 3, 20244Insider transaction (Form 4)
Nov 21, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Oct 2, 20244Insider transaction (Form 4)
Aug 26, 20244Insider transaction (Form 4)
Aug 23, 2024144/ANotice of proposed sale (Form 144), amended
Aug 22, 2024144Notice of proposed sale (Form 144)
Aug 16, 2024144Notice of proposed sale (Form 144)
Aug 15, 2024144Notice of proposed sale (Form 144)
Aug 9, 2024144Notice of proposed sale (Form 144)
Aug 7, 20244Insider transaction (Form 4)
Aug 7, 20244Insider transaction (Form 4)
Aug 7, 20244Insider transaction (Form 4)
Aug 7, 20244Insider transaction (Form 4)
Aug 7, 20244Insider transaction (Form 4)
Aug 6, 2024144Notice of proposed sale (Form 144)
Jul 30, 2024144Notice of proposed sale (Form 144)
Jul 25, 2024144Notice of proposed sale (Form 144)
Jul 3, 20244Insider transaction (Form 4)
Jul 3, 20243Initial insider holdings (Form 3)
Jul 2, 20244Insider transaction (Form 4)

The newest 25 of 98 shown; the full year is on EDGAR.

2023 · 76 filings — 52 × 4, 16 × 144, 4 × SC 13G/A and 3 other forms

Counted, not listed; the year is on EDGAR.

2022 · 53 filings — 46 × 4, 4 × SC 13G/A, 3 × SC 13D/A

Counted, not listed; the year is on EDGAR.

2021 · 118 filings — 111 × 4, 3 × SC 13D/A, 3 × SC 13G/A and 1 other form

Counted, not listed; the year is on EDGAR.

2020 · 82 filings — 72 × 4, 4 × SC 13D/A, 2 × SC 13G/A and 4 other forms

Counted, not listed; the year is on EDGAR.

2019 · 59 filings — 37 × 4, 5 × UPLOAD, 3 × 4/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2018 · 47 filings — 27 × 4, 8 × 424B7, 6 × SC 13D/A and 2 other forms

Counted, not listed; the year is on EDGAR.

2017 · 28 filings — 11 × 4, 3 × CORRESP, 3 × SC 13D/A and 7 other forms

Counted, not listed; the year is on EDGAR.

2016 · 52 filings — 14 × 3, 11 × 4, 6 × CORRESP and 12 other forms

Counted, not listed; the year is on EDGAR.

About this data

Medpace Holdings Inc. (MEDP) has 920 filings on EDGAR going back to 2016: 10 annual reports, 30 quarterly reports and 89 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Jul 22, 2026, covered results of operations. Over the last 13 months insiders sold $230.3M in 33 sales and bought nothing on the open market; 64 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Medpace Holdings Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read MEDP's latest 10-K?
MEDP's latest annual report, a 10-K, was filed on Feb 10, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
When did MEDP last file an 8-K?
On Jul 22, 2026: results of operations. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Jul 22, 2026.
Are MEDP insiders buying or selling?
Over the last 13 months insiders sold $230.3M in 33 sales and bought nothing on the open market; 64 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Troendle August J. (President & CEO · Director · 10% owner) sold 21,966 shares on Sep 30, 2026 for $13.7M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
How many SEC filings has MEDP made?
920 filings are on EDGAR under the registrant records that have been Medpace Holdings Inc., going back to 2016; 651 of them are insider ownership forms (Forms 3, 4, 5 and 144).